Related Experiment Video
Updated: Jun 5, 2025

Influenza Virus Propagation in Embryonated Chicken Eggs
Published on: March 19, 2015
Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023-2024
Abstract:
We show that human myxovirus resistance protein 1 (MxA) suppresses replication of highly pathogenic avian influenza A(H5N1) viruses isolated from mammals in vitro and in MxA-transgenic mice. However, H5N1 can evade MxA restriction through replacement of individual viral polymerase complex components from a human-adapted MxA-resistant strain in vitro.
Insights
Human myxovirus resistance protein 1 (MxA) inhibits avian influenza A(H5N1) virus replication. However, H5N1 can evade MxA restriction by acquiring specific viral components from resistant strains.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Highly pathogenic avian influenza A(H5N1) viruses pose a significant threat to public health.
- Human myxovirus resistance protein 1 (MxA) is a key innate immune factor known to restrict viral replication.
Purpose of the Study:
- To investigate the antiviral activity of human MxA against avian influenza A(H5N1) viruses.
- To elucidate the mechanisms by which H5N1 viruses may evade MxA-mediated restriction.
Main Methods:
- In vitro replication assays using H5N1 isolates and MxA-expressing cells.
- In vivo studies utilizing MxA-transgenic mouse models.
- Analysis of viral polymerase complex component exchange.
Main Results:
- Human MxA demonstrably suppressed the replication of H5N1 viruses in both cell culture and transgenic mice.
- H5N1 viruses exhibited the ability to evade MxA restriction.
- Evading MxA involved the acquisition of specific viral polymerase components from a human-adapted, MxA-resistant strain.
Conclusions:
- Human MxA is an effective antiviral factor against H5N1 influenza A viruses.
- Avian influenza A(H5N1) viruses possess mechanisms to overcome MxA-mediated innate immunity.
- Understanding viral evasion strategies is crucial for developing effective antiviral therapies against influenza.
More Related Videos
07:15Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Published on: November 22, 2021
12:09Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
Published on: November 22, 2017
Related Concept Videos
Leaky Scanning
Viral Recombination
Viral Mutations